Maxor National Pharmacy Services LLC this week announced that an agreement has been reached for its acquisition of Pharmaceutical Specialties Inc. (PSI).
Under the agreement, Maxor Specialty/IV Solutions will be combing its clinical expertise and high-touch patient service models with that of PSI to create a specialty pharmacy to serve patients, physicians, manufacturers and payers.
"Maxor shares the philosophy of PSI's case management approach to patient care,” PSI Founder and President Keith Sledge said. “This model provides individualized patient care along with prompt service to eliminate unnecessary delays in treatment, allowing our patients to achieve optimal benefit from their prescribed therapies.”
Maxor’s acquisition of PSI is expected to be finalized in the fourth quarter of this year. The financial terms of the deal have not yet been disclosed.
"Maxor and PSI have both offered innovative, clinically-focused specialty pharmacy services for more than 20 years,” Maxor CEO Mike Ellis said. “Combining these two companies brings national scale, clinical excellence, and operational capabilities while maintaining individual patient focus; enabling us to further lead and serve our Specialty Pharmacy customers.”